News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
529,574 Results
Type
Article (26750)
Company Profile (388)
Press Release (502423)
Multimedia
Podcasts (84)
Webinars (16)
Section
Business (148167)
Career Advice (876)
Deals (25796)
Drug Delivery (68)
Drug Development (66857)
Employer Resources (97)
FDA (12461)
Job Trends (11125)
News (252561)
Policy (19500)
Tag
Academia (2076)
Accelerated approval (20)
Adcomms (18)
Allergies (105)
Alliances (41481)
ALS (149)
Alzheimer's disease (1417)
Antibody-drug conjugate (ADC) (270)
Approvals (12674)
Artificial intelligence (478)
Autoimmune disease (109)
Automation (33)
Bankruptcy (194)
Best Places to Work (9711)
BIOSECURE Act (12)
Biosimilars (129)
Biotechnology (287)
Bladder cancer (136)
Brain cancer (50)
Breast cancer (560)
Cancer (4243)
Cardiovascular disease (319)
Career advice (783)
Career pathing (22)
CAR-T (256)
CDC (18)
Cell therapy (689)
Cervical cancer (33)
Clinical research (57241)
Collaboration (1495)
Company closure (4)
Compensation (799)
Complete response letters (45)
COVID-19 (1816)
CRISPR (86)
C-suite (662)
Cystic fibrosis (135)
Data (5335)
Decentralized trials (2)
Denatured (22)
Depression (110)
Diabetes (371)
Diagnostics (5419)
Digital health (37)
Diversity (7)
Diversity, equity & inclusion (31)
Drug discovery (215)
Drug pricing (80)
Drug shortages (11)
Duchenne muscular dystrophy (206)
Earnings (57947)
Editorial (29)
Employer branding (11)
Employer resources (89)
Events (86856)
Executive appointments (931)
FDA (15025)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (7)
Frontotemporal dementia (20)
Funding (1338)
Gene editing (190)
Generative AI (38)
Gene therapy (535)
GLP-1 (673)
Government (2609)
Grass and pollen (4)
Guidances (347)
Healthcare (15173)
HIV (39)
Huntington's disease (38)
IgA nephropathy (75)
Immunology and inflammation (200)
Immuno-oncology (30)
Indications (73)
Infectious disease (2007)
Inflammatory bowel disease (179)
Inflation Reduction Act (10)
Influenza (87)
Intellectual property (198)
Interviews (129)
IPO (12655)
IRA (18)
Job creations (1825)
Job search strategy (663)
Kidney cancer (16)
Labor market (42)
Layoffs (360)
Leadership (23)
Legal (3246)
Liver cancer (79)
Longevity (12)
Lung cancer (609)
Lymphoma (311)
Machine learning (35)
Management (32)
Manufacturing (582)
MASH (151)
Medical device (11152)
Medtech (11186)
Mergers & acquisitions (14078)
Metabolic disorders (932)
Multiple sclerosis (122)
NASH (17)
Neurodegenerative disease (265)
Neuropsychiatric disorders (70)
Neuroscience (2452)
NextGen: Class of 2025 (5152)
Non-profit (3158)
Now hiring (36)
Obesity (391)
Opinion (204)
Ovarian cancer (148)
Pain (165)
Pancreatic cancer (186)
Parkinson's disease (252)
Partnered (28)
Patents (399)
Patient recruitment (365)
Peanut (50)
People (45566)
Pharmaceutical (57)
Pharmacy benefit managers (16)
Phase I (19054)
Phase II (25773)
Phase III (18111)
Pipeline (3492)
Policy (142)
Postmarket research (1438)
Preclinical (7913)
Press Release (55)
Prostate cancer (205)
Psychedelics (49)
Radiopharmaceuticals (267)
Rare diseases (685)
Real estate (3890)
Recruiting (35)
Regulatory (16921)
Reports (26)
Research institute (2035)
Resumes & cover letters (106)
Rett syndrome (22)
RNA editing (16)
RSV (50)
Schizophrenia (133)
Series A (223)
Series B (170)
Service/supplier (10)
Sickle cell disease (90)
Special edition (19)
Spinal muscular atrophy (132)
Sponsored (36)
Startups (2949)
State (2)
Stomach cancer (16)
Supply chain (79)
Tariffs (33)
The Weekly (61)
Vaccines (590)
Venture capital (65)
Weight loss (227)
Women's health (58)
Worklife (9)
Date
Last 7 days (601)
Last 30 days (2217)
Last 365 days (27979)
2025 (27208)
2024 (32099)
2023 (35938)
2022 (45762)
2021 (48588)
2020 (45204)
2019 (37068)
2018 (27471)
2017 (26083)
2016 (23826)
2015 (27677)
2014 (20675)
2013 (16392)
2012 (17193)
2011 (17226)
2010 (15291)
Location
Africa (431)
Alabama (83)
Alaska (6)
Arizona (161)
Arkansas (11)
Asia (30583)
Australia (4916)
California (9594)
Canada (2622)
China (919)
Colorado (400)
Connecticut (431)
Delaware (290)
Europe (70373)
Florida (1410)
Georgia (320)
Hawaii (2)
Idaho (49)
Illinois (657)
India (49)
Indiana (476)
Iowa (20)
Japan (347)
Kansas (117)
Kentucky (35)
Louisiana (16)
Maine (41)
Maryland (1108)
Massachusetts (7045)
Michigan (264)
Minnesota (538)
Mississippi (6)
Missouri (116)
Montana (33)
Nebraska (16)
Nevada (95)
New Hampshire (72)
New Jersey (2493)
New Mexico (27)
New York (2512)
North Carolina (1340)
North Dakota (10)
Northern California (4574)
Ohio (301)
Oklahoma (22)
Oregon (40)
Pennsylvania (1929)
Puerto Rico (16)
Rhode Island (43)
South America (646)
South Carolina (54)
South Dakota (1)
Southern California (3712)
Tennessee (139)
Texas (1430)
United States (33994)
Utah (245)
Vermont (1)
Virginia (220)
Washington D.C. (60)
Washington State (766)
West Virginia (4)
Wisconsin (104)
Wyoming (2)
529,574 Results for "hitachi chemical advanced therapeutics solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
1910 Publishes CANDID-CNS™, an AI Model That Unlocks Beyond Rule of 5 Chemical Space and Stereochemistry to Predict Blood–Brain Barrier Penetration
● CANDID-CNS™ is the new state-of-the-art AI model for BBB penetration: it achieves 87% AUPRC on bRo5 small molecules compared to 56% by Pfizer’s CNS MPO. ● CANDID-CNS™ distinguishes CNS penetrant stereoisomers at 68% compared to 50% by Pfizer’s CNS MPO. ● Published in the Journal of Chemical Information and Modeling, CANDID-CNS™ presents a breakthrough in AI Drug Discovery by unlocking the potential of bRo5 and stereochemistry to significantly expand the chemical space of small molecules that can be developed into CNS therapeutics.
December 4, 2025
·
1 min read
Press Releases
Innova Therapeutics to Advance Novel Cancer Treatment with Enci Therapeutics Acquisition
November 26, 2025
·
5 min read
RayStation Used for First-Ever Radiotherapy Treatment with Hitachi’s OXRAY system
RaySearch Laboratories AB (publ) is pleased to announce a milestone in radiotherapy technology where RaySearch’s RayStation®* was used for the world’s first clinical treatment using OXRAY, a new treatment machine from Hitachi.
June 18, 2024
·
3 min read
Sponsored
Accelerating Timelines and Reducing Cost in Early Clinical Drug Development With ICON’s Accelerated Pharmaceutical Solutions
Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced formulation design, real-time dose flexibility, and cutting-edge CMC expertise to transform complexity into clarity. By uniting science, technology, and strategy, biotechs can move faster, smarter, and with confidence—turning obstacles into opportunities for breakthrough success.
December 8, 2025
·
5 min read
·
Arjen Akkerman
Press Releases
Gentuity Announces Activities and Presence to Showcase Advanced Intravascular Imaging Solutions at TCT 2025
October 24, 2025
·
4 min read
Press Releases
Luxna Deepens Collaboration with BioSpring to Advance Therapeutic Oligonucleotide Development
December 2, 2025
·
1 min read
Business
Roche and Hitachi High-Tech extend their 46-year partnership, paving the way for further breakthroughs in diagnostic testing
Roche announced that Hitachi High-Tech and Roche have extended their partnership, committing to at least 10 years of additional collaboration.
May 27, 2024
·
5 min read
Press Releases
Praxis Packaging Solutions Expands with Acquisition of Advanced Concept Innovations, LLC
September 25, 2025
·
1 min read
Press Releases
Pluristyx and Solesis Announce Strategic Collaboration to Advance Organoid and Cell Therapy Solutions
September 25, 2025
·
3 min read
Press Releases
Lisata Therapeutics Wins 2025 BioTech Breakthrough Award for ‘Overall BioPharma Solution of the Year’
November 7, 2025
·
10 min read
1 of 52,958
Next